60 related articles for article (PubMed ID: 26856288)
1. Frequency and clinical impact of ETV6/RUNX1, AF4-MLL, and BCR/ABL fusion genes on features of acute lymphoblastic leukemia at presentation.
Ajuba IC; Madu AJ; Okocha C; Ibegbulam OG; Okpala I; Nna OE
Niger J Clin Pract; 2016; 19(2):237-41. PubMed ID: 26856288
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene.
Menendez P; Catalina P; Rodríguez R; Melen GJ; Bueno C; Arriero M; García-Sánchez F; Lassaletta A; García-Sanz R; García-Castro J
J Exp Med; 2009 Dec; 206(13):3131-41. PubMed ID: 19995953
[TBL] [Abstract][Full Text] [Related]
3. Rare concomitance of ETV6::RUNX1 and BCR::ABL1p210 in a child diagnosed with B-cell precursor acute lymphoblastic leukemia.
Barbosa TC; Oliveira E; Blunck CB; Maciel A; Bastos A; Bouzada H; Rouxinol ST; Mansur MB; Costa ES; Almeida CW; Emerenciano M
Cancer Genet; 2023 Aug; 276-277():40-42. PubMed ID: 37480760
[No Abstract] [Full Text] [Related]
4. [Leukemia Genotype Analysis of Children with Acute Lymphoblastic Leukemia in Yunnan Area].
Shi SL; Kui LY; Xia SM; Zhou BL; Li RJ; Jiang HC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):980-984. PubMed ID: 37551465
[TBL] [Abstract][Full Text] [Related]
5. Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1-positive pediatric leukemia identifies drug-targetable transcription factor activities.
Mehtonen J; Teppo S; Lahnalampi M; Kokko A; Kaukonen R; Oksa L; Bouvy-Liivrand M; Malyukova A; Mäkinen A; Laukkanen S; Mäkinen PI; Rounioja S; Ruusuvuori P; Sangfelt O; Lund R; Lönnberg T; Lohi O; Heinäniemi M
Genome Med; 2020 Nov; 12(1):99. PubMed ID: 33218352
[TBL] [Abstract][Full Text] [Related]
6. Fishing for ETV6/RUNX1 fusion and MLL gene rearrangements and their additional abnormalities in childhood acute lymphoblastic leukemia patients of Kashmir.
Mohiuddin Malla T; Amin Shah Z; Hussain Bhat A; Ahmad Malik M; Anjum Baba R; Rasool R; Rasool J; Ashaq S; Haq F
Gene; 2023 Mar; 856():147128. PubMed ID: 36565795
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and literature review of ETV6::ABL1 fusion gene-positive acute myeloid leukemia.
Xue S; Sun HP; Huang XB; Chen X; Wang T; Ma W; Tian Y; Pan ZL; Li LH; Zhang L; Liu HX; Cao XY
Int J Hematol; 2024 May; 119(5):564-572. PubMed ID: 38441775
[TBL] [Abstract][Full Text] [Related]
8. MiR-27a downregulates 14-3-3θ, RUNX1, AF4, and MLL-AF4, crucial drivers of blast transformation in t(4;11) leukemia cells.
Fioretti T; Zanobio M; Raia M; Errichiello S; Izzo B; Cattaneo F; Ammendola R; Cevenini A; Esposito G
Cell Biochem Funct; 2022 Oct; 40(7):706-717. PubMed ID: 35981137
[TBL] [Abstract][Full Text] [Related]
9. A causal mechanism for childhood acute lymphoblastic leukaemia.
Greaves M
Nat Rev Cancer; 2018 Aug; 18(8):471-484. PubMed ID: 29784935
[TBL] [Abstract][Full Text] [Related]
10. Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.
Paietta E; Roberts KG; Wang V; Gu Z; Buck GAN; Pei D; Cheng C; Levine RL; Abdel-Wahab O; Cheng Z; Wu G; Qu C; Shi L; Pounds S; Willman CL; Harvey R; Racevskis J; Barinka J; Zhang Y; Dewald GW; Ketterling RP; Alejos D; Lazarus HM; Luger SM; Foroni L; Patel B; Fielding AK; Melnick A; Marks DI; Moorman AV; Wiernik PH; Rowe JM; Tallman MS; Goldstone AH; Mullighan CG; Litzow MR
Blood; 2021 Sep; 138(11):948-958. PubMed ID: 33895809
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of
Qiu KY; Liao XY; Huang K; Xu HG; Li Y; Zhou DH; Fang JP
Transl Cancer Res; 2023 Oct; 12(10):2952-2958. PubMed ID: 37969368
[TBL] [Abstract][Full Text] [Related]
12. A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features.
Bueno C; Torres-Ruiz R; Velasco-Hernandez T; Molina O; Petazzi P; Martinez A; Rodriguez V; Vinyoles M; Cantilena S; Williams O; Vega-Garcia N; Rodriguez-Perales S; Segovia JC; Quintana-Bustamante O; Roy A; Meyer C; Marschalek R; Smith AL; Milne TA; Fraga MF; Tejedor JR; Menéndez P
Blood; 2023 Nov; 142(20):1752-1756. PubMed ID: 37756522
[TBL] [Abstract][Full Text] [Related]
13. Space-Time Clustering of Childhood Leukemia: Evidence of an Association with ETV6-RUNX1 (TEL-AML1) Fusion.
Kreis C; Lupatsch JE; Niggli F; Egger M; Kuehni CE; Spycher BD;
PLoS One; 2017; 12(1):e0170020. PubMed ID: 28129329
[TBL] [Abstract][Full Text] [Related]
14. First Case of
Jeon SJ; Park JH; Lim H; Won EJ; Choi H; Choi HJ; Kee SJ; Kim SH; Shin JH; Shin MG
Ann Lab Med; 2023 Jan; 43(1):92-95. PubMed ID: 36045062
[No Abstract] [Full Text] [Related]
15.
de Matos RRC; Ferreira GM; Bonecker S; Rouxinol M; da Costa ES; Mello FV; Abdelhay E; Ribeiro RC; Zalcberg I; Silva MLM
Leuk Lymphoma; 2023 Dec; 64(12):2042-2046. PubMed ID: 37548333
[No Abstract] [Full Text] [Related]
16. B-cell acute lymphoblastic leukemia and juvenile xanthogranuloma in a patient with
Newman H; MacFarland SP; Brodeur GM; Olson T; Bhojwani D; Stokke J; Kovach AE; Clark ME; Luo M; Li M; Shah A; Hunger SP
Haematologica; 2024 May; 109(5):1624-1627. PubMed ID: 38031764
[No Abstract] [Full Text] [Related]
17. An ETV6::NTRK3 fusion transcript in a core-binding factor acute myeloid leukemia.
Coster L; Huguet F; Canali A; Rieu JB; De Mas VM
EJHaem; 2023 Aug; 4(3):867-868. PubMed ID: 37601839
[No Abstract] [Full Text] [Related]
18. Identification of the characteristics and prognostic impact of FUS::ERG and RUNX1::CBFA2T3 fusion genes in adult acute myeloid leukemia patients.
Zhou Z; Zhuo N; Zhou Y; Sun C; Yao Y; Mao L; Zhang Y; Hong Q; Pan P; Tong H; Jin J; Wang H
Am J Hematol; 2024 Apr; ():. PubMed ID: 38651500
[No Abstract] [Full Text] [Related]
19. Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes.
Messina M; Chiaretti S; Wang J; Fedullo AL; Peragine N; Gianfelici V; Piciocchi A; Brugnoletti F; Di Giacomo F; Pauselli S; Holmes AB; Puzzolo MC; Ceglie G; Apicella V; Mancini M; Te Kronnie G; Testi AM; Vitale A; Vignetti M; Guarini A; Rabadan R; Foà R
Oncotarget; 2016 Mar; 7(12):13886-901. PubMed ID: 26883104
[TBL] [Abstract][Full Text] [Related]
20. Gaq signaling is required for the maintenance of MLL-AF9-induced acute myeloid leukemia.
Lynch JR; Yi H; Casolari DA; Voli F; Gonzales-Aloy E; Fung TK; Liu B; Brown A; Liu T; Haber M; Norris MD; Lewis ID; So CW; D'Andrea RJ; Wang JY
Leukemia; 2016 Aug; 30(8):1745-8. PubMed ID: 26859074
[No Abstract] [Full Text] [Related]
[Next] [New Search]
